Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-01-01 @ 11:28 PM
Study NCT ID:
NCT04985604
Status:
TERMINATED
Last Update Posted:
2025-10-02
First Post:
2021-06-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors
Sponsor:
Day One Biopharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-15
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-08
Completion Date Type:
ACTUAL
First Submit Date:
2021-06-23
First Submit QC Date:
None
Study First Post Date:
2021-08-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-06-26
Results First Submit QC Date:
None
Results First Post Date:
2025-10-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-12
Last Update Post Date:
2025-10-02
Last Update Post Date Type:
ESTIMATED